Challenges and Priorities for Children With Congenital Valvar Heart Disease: The Heart Valve Collaboratory.

Autor:	Bauser-Heaton H; Department of Pediatric Cardiology, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Barry OM; Division of Pediatric Cardiology, New York Presbyterian Hospital, Columbia University Vagelos College of Physician and Surgeons, New York, New York, USA., Hofferberth SC; Division of Cardiac Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical school, Boston, Massachusetts, USA., Tretter JT; Department of Pediatric Cardiology, and The Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland Clinic Children's Hospital, Cleveland, Ohio, USA., Ma M; Division of Cardiothoracic Surgery, Stanford Medicine Children's Health, Stanford University, Palo Alto, California, USA., Goldstone A; Department of Cardiac Surgery, New York Presbyterian Hospital, Columbia University Vagelos College of Physician and Surgeons, New York, New York, USA., Armstrong A; Division of Pediatric Cardiology, Nationwide Children's Hospital, Columbus, Ohio, USA., Jones TK; Division of Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA., Yoganathan A; Emeritus Regents' Professor Biomedical Engineering Georgia Institute of Technology, Atlanta, Georgia, USA., Del Nido P; Division of Cardiothoracic Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Jazyk:	angličtina
Zdroj:	JACC. Advances [JACC Adv] 2024 Sep 06; Vol. 3 (10), pp. 101191. Date of Electronic Publication: 2024 Sep 06 (Print Publication: 2024).
DOI:	10.1016/j.jacadv.2024.101191
Abstrakt:	The Heart Valve Collaboratory is a multidisciplinary, patient-centered community of stakeholders addressing complex problems and embracing innovation to help patients with heart valve disease achieve their fullest potential for health. The Scientific Council is composed of cardiologists, surgeons, ex-officio representatives of the Food and Drug Administration and Centers for Medicare and Medicaid Services, National Heart Lung Blood Institute, and representatives from industry partners. In October 2022, this group convened a workshop that included experts from stakeholder groups to address the unmet and clinical needs of patients with pediatric and congenital heart valve disease. The following document includes the discussion and summary of the current state of valve therapy and the needs being addressed for valve development. Competing Interests: Dr Hofferberth is an employee, board member, and equity holder for Autus Valve Technologies, Inc. Dr Tretter is a consultant for Cara Medical Ltd. Dr Armstrong is a consultant for Medtronic and Edwards Lifesciences. Dr Jones is an investigator, consultant, and proctor for Medtronic; and has received research support and is a consultant for Edwards Lifesciences. Dr Nido is a consultant for Autus Valve Technologies, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (© 2024 Published by Elsevier on behalf of the American College of Cardiology Foundation.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu